CSF2 and essential thrombocythemia: Five ET patients with vascular event (including thrombosis, cardiovascular events and/or strokes) exhibited lower levels of IL-17, CCL5, GM-CSF, and VEGF than ET patients with no vascular event (n = 17) (Figure 4A).